These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Intrasubject comparison of regional cerebral blood flow between N-isopropyl-p-[123I]iodoamphetamine SPECT and 99mTc-hexamethylpropyleneamine oxime SPECT in patients with ischemic cerebrovascular disease]. Isaka Y, Yoshikawa T, Ohe Y, Nakayama H, Abe T, Ashida K, Imaizumi M, Tanaka S. Kaku Igaku; 1995 Feb; 32(2):131-8. PubMed ID: 7715098 [Abstract] [Full Text] [Related]
3. [Comparison of cerebral vasoreactivity to acetazolamide in normal volunteer among 123I-IMP, 99mTc-ECD and 99mTc-HMPAO]. Makino K, Masuda Y, Gotoh S. Kaku Igaku; 1996 May; 33(5):551-5. PubMed ID: 8699624 [Abstract] [Full Text] [Related]
4. Double-tracer SPECT in patients with AIDS encephalopathy: a comparison of 123I-IMP with 99Tcm-HMPAO. Pohl P, Riccabona G, Hilty E, Deisenhammer F, Rösslér H, Zangerle R, Gerstenbrand F. Nucl Med Commun; 1992 Aug; 13(8):586-92. PubMed ID: 1513520 [Abstract] [Full Text] [Related]
5. "Luxury perfusion" with 99mTc-HMPAO and 123I-IMP SPECT imaging during the subacute phase of stroke. Moretti JL, Defer G, Cinotti L, Cesaro P, Degos JD, Vigneron N, Ducassou D, Holman BL. Eur J Nucl Med; 1990 Aug; 16(1):17-22. PubMed ID: 2307169 [Abstract] [Full Text] [Related]
6. Technetium-99m-HMPAO, technetium-99m-ECD and iodine-123-IMP cerebral blood flow measurements with pharmacological interventions in primates. Dormehl IC, Oliver DW, Langen KJ, Hugo N, Croft SA. J Nucl Med; 1997 Dec; 38(12):1897-901. PubMed ID: 9430465 [Abstract] [Full Text] [Related]
7. [A comparative study of the quality of SPECT images obtained by 123I-IMP, 99mTc-HMPAO and 99mTc-ECD]. Odano I, Ohkubo M, Takahashi M, Noguchi E, Ohtaki H, Kasahara T, Shibaki M, Hatano M. Kaku Igaku; 1997 Mar; 34(3):189-94. PubMed ID: 9136527 [Abstract] [Full Text] [Related]
8. [Quantitation of regional cerebral blood flow by single photon emission computed tomography of CBF-tracer combined with whole-brain CBF: a comparison between 123I-IMP and 99mTc-HMPAO in healthy volunteers]. Isaka Y, Imaizumi M, Ashida K, Ohe Y, Okamoto M, Abe T, Tanaka S. Kaku Igaku; 1994 May; 31(5):423-9. PubMed ID: 8028214 [Abstract] [Full Text] [Related]
9. [The semiquantitative measurement method of cerebral blood flow using SPECT image]. Boku A. Hokkaido Igaku Zasshi; 1995 May; 70(3):413-27. PubMed ID: 7590593 [Abstract] [Full Text] [Related]
10. Comparison of 99Tcm complexes (NEP-DADT, ME-NEP-DADT and HMPAO) with 123IAMP for brain SPECT imaging in dogs. Bok BD, Scheffel U, Goldfarb HW, Burns HD, Lever SZ, Wong DF, Bice A, Wagner HN. Nucl Med Commun; 1987 Aug; 8(8):631-41. PubMed ID: 3501084 [Abstract] [Full Text] [Related]
11. Quantitative 123I IMP and 99mTc HMPAO imaging in the dog following cocaine administration. Susskind H, Weber DA, Ivanovic M, Wong CT, DeHaan CE, Gavin PR. Nucl Med Biol; 1996 Apr; 23(3):343-52. PubMed ID: 8782246 [Abstract] [Full Text] [Related]
12. A 99Tcm-labelled radiotracer for the investigation of cerebral vascular disease. Ell PJ, Hocknell JM, Jarritt PH, Cullum I, Lui D, Campos-Costa D, Nowotnik DP, Pickett RD, Canning LR, Neirinckx RD. Nucl Med Commun; 1985 Aug; 6(8):437-41. PubMed ID: 3877889 [Abstract] [Full Text] [Related]
13. Comparative study of regional cerebral blood flow images by SPECT using xenon-133, iodine-123 IMP, and technetium-99m HM-PAO. Nakano S, Kinoshita K, Jinnouchi S, Hoshi H, Watanabe K. J Nucl Med; 1989 Feb; 30(2):157-64. PubMed ID: 2786931 [Abstract] [Full Text] [Related]
14. Does the washout phenomenon of Tc-99m HM-PAO correlate to the "filling-in" phenomenon of I-123 IMP with brain SPECT? Hayashida K, Nishimura T, Imakita S, Uehara T. Neuroradiology; 1990 Feb; 32(3):196-9. PubMed ID: 2215903 [Abstract] [Full Text] [Related]
16. [The usefulness of single photon emission computed tomography using N-isopropyl-p-[123I]-iodoamphetamine and 99mTc-hexamethylpropyleneamine oxime in patients with moyamoya disease]. Morita K, Ono S, Fukunaga M, Otsuka N, Nagai K, Furukawa T, Muranaka A, Mimura H, Yanagimoto S, Tomomitsu T. Kaku Igaku; 1990 Jan; 27(1):69-80. PubMed ID: 2338770 [No Abstract] [Full Text] [Related]
18. [Evaluation of SPECT with N-isopropyl [I-123]-p-iodoamphetamine (IMP) or technetium-99m [99mTc]-d,l-hexamethylpropyleneamine oxime (d, 1-HM-PAO) in cerebral concussion]. Torigoe R, Hayashi T, Anegawa S, Harada K, Matsuo H, Yoshikawa I. No To Shinkei; 1991 Jun; 43(6):530-5. PubMed ID: 1910937 [Abstract] [Full Text] [Related]
19. [Difference in the distribution of 123I-IMP and 99mTc-HMPAO in the striatum--comparison with 15O-PET]. Otsuka M, Ichiya Y, Kuwabara Y, Sasaki M, Akashi Y, Yoshida T, Fukumura T, Masuda K. Kaku Igaku; 1993 Apr; 30(4):389-95. PubMed ID: 8315889 [Abstract] [Full Text] [Related]
20. SPECT images of technetium-99m-ethyl cysteinate dimer in cerebrovascular diseases: comparison with other cerebral perfusion tracers and PET. Tsuchida T, Nishizawa S, Yonekura Y, Sadato N, Iwasaki Y, Fujita T, Matoba N, Magata Y, Tamaki N, Konishi J. J Nucl Med; 1994 Jan; 35(1):27-31. PubMed ID: 8271056 [Abstract] [Full Text] [Related] Page: [Next] [New Search]